- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 11.08. | Filament Health Corp. reports Q2 results | 2 | Seeking Alpha | ||
| 11.08. | Filament Health Announces Second Quarter 2025 Financial Results And Operational Highlights | 1 | CNW | ||
| 31.07. | Filament Health Announces First-ever Compassionate Use Approval For Psilocybin In The European Union | 1 | CNW | ||
| 24.07. | Filament Health Announces Two Phase 2 Research Trials In Partnership With University College London | 1 | CNW | ||
| 08.07. | Jaguar Health, Inc.: Coca Access and Benefit Sharing Agreement Authorized by Peru's National Institute of Agrarian Innovation Supports Research Efforts of Jaguar Health and Filament Health Joint Venture, Magdalena Biosciences, into Potential Mental Health | 498 | ACCESS Newswire | Magdalena is focused on developing novel, natural prescription medicines derived from plants for mental health indications SAN FRANCISCO, CA / ACCESS Newswire / July 8, 2025 /
Jaguar Health, Inc.
(NASDAQ:JAGX)
... ► Artikel lesen | |
| 07.07. | Filament Health Announces Fda Authorization Of Phase 2 Clinical Trial Studying Psilocybin For Alcohol Use Disorder And Post-traumatic Stress Disorder In Veterans And First Responders | 1 | CNW | ||
| 17.06. | Filament Health Enters Into Exclusive License Agreement With University Of Alabama At Birmingham For Data From A Clinical Trial Of Psilocybin For The Treatment Of Cocaine Use Disorder | 2 | CNW | ||
| FILAMENT HEALTH Aktie jetzt für 0€ handeln | |||||
| 11.06. | Filament Health Announces Authorization Of Phase 2 Clinical Trial Studying Botanical Psilocybin For Prolonged Grief Disorder | 1 | CNW | ||
| 28.05. | Filament Health Announces Transition From Otcqb To Otc Pink Limited | 3 | CNW | ||
| 22.05. | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 22.05.2025 | 762 | Xetra Newsboard | The following instruments on Boerse Frankfurt do have their last trading day on 22.05.2025.Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 22.05.2025.ISIN NameCA31685W1068 FILAMENT... ► Artikel lesen | |
| 22.05. | XFRA 7QS: AUSSETZUNG/SUSPENSION | 234 | Xetra Newsboard | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILFILAMENT HEALTH... ► Artikel lesen | |
| 20.05. | Filament Health Corp: Filament shares to delist from Cboe Canada May 21 | 1 | Stockwatch | ||
| 19.05. | Filament Health Corp.: Filament Health Announces Voluntary Delisting From Cboe Canada | 177 | PR Newswire | VANCOUVER, BC, May 19, 2025 /CNW/ - Filament Health Corp. (OTCQB: FLHLF) (CBOE: FH) (FSE: 7QS) ("Filament" or the "Company"), a clinical-stage natural psychedelic... ► Artikel lesen | |
| 09.05. | Filament Health reports Q1 results | 1 | Seeking Alpha | ||
| 09.05. | Filament Health Corp.: Filament Health Announces First Quarter 2025 Financial Results And Operational Highlights | 87 | PR Newswire | VANCOUVER, BC, May 8, 2025 /CNW/ - Filament Health Corp. (OTCQB: FLHLF) (CBOE: FH) (FSE: 7QS) ("Filament" or the "Company"), a clinical-stage natural psychedelic... ► Artikel lesen | |
| 04.04. | Filament Health Corp.: Filament Health Announces Private Placement And Intention To Voluntarily Delist From Cboe Canada | 165 | PR Newswire | Financing driven by existing investor Negev and Filament's Board of Directors
Company also announces intention to voluntarily delist from Cboe Canada
VANCOUVER... ► Artikel lesen | |
| 01.04. | Filament Health Corp.: Filament Health Reports Q4 And Year End 2024 Financial Results And Operational Highlights | 124 | PR Newswire | VANCOUVER, BC, April 1, 2025 /CNW/ - Filament Health Corp. (OTCQB: FLHLF) (NEO: FH) (FSE: 7QS) ("Filament" or the "Company"), a clinical-stage natural psychedelic... ► Artikel lesen | |
| 17.03. | Filament Health Corp.: Filament Health Announces Positive Data From Phase 2 Study Of Pex010 In Patients With Alcohol Use Disorder | 104 | PR Newswire | Open-label study at Psychiatric Centre Copenhagen found that alcohol consumption significantly decreased amongst participants dosed with Filament's botanical psilocybin... ► Artikel lesen | |
| 06.02. | Jaguar Health, Inc.: Magdalena Biosciences, a Joint Venture Between Jaguar Health and Filament Health, to Present February 10th at BIO CEO & Investor Conference | 481 | ACCESS Newswire | Magdalena aiming to submit Investigational New Drug (IND) application in 2025 to the FDA for a next-generation psychoactive prescription drug candidate for potential mental health indications such as... ► Artikel lesen | |
| 07.01. | Jaguar Health, Inc.: Magdalena Biosciences, a Joint Venture Between Jaguar Health and Filament Health, to Present January 12 at the Annual Neuroscience Innovation Forum | 486 | ACCESS Newswire | Magdalena aiming to submit Investigational New Drug (IND) application in early 2025 to the FDA for a next-generation psychoactive prescription drug candidate for potential mental health indications... ► Artikel lesen |
1 2 Weiter >>
21 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BAYER | 27,800 | -0,64 % | Krebsforschung mit Milliarden-Potenzial: So könnten Bayer, Vidac Pharma und BioNTech ins Spiel kommen | Der Onkologie-Markt brummt wie kaum ein anderer. Getrieben von technologischen Quantensprüngen und leider auch steigenden Fallzahlen, entwickelt sich die Krebsbehandlung zum lukrativen Innovationsmotor.... ► Artikel lesen | |
| AURORA CANNABIS | 4,850 | +6,36 % | Piramal Pharma Solutions Implements POD Method at Aurora API Facility | ||
| CANOPY GROWTH | 1,278 | +7,94 % | Canopy Growth Corp (2): Canopy's DOJA facility now a medical cultivation site | ||
| TILRAY BRANDS | 1,550 | +4,91 % | Tilray Brands-Aktie: Geht das Mega-Comeback weiter? | Die Tilray Brands-Aktie erlebt dieser Tage ein heftiges Auf und Ab. Nachdem der Kurs des Cannabis- und Getränkeherstellers am Donnerstag um über +20% in die Höhe schoss, gab er am Freitag fast den gesamten... ► Artikel lesen | |
| INNOCAN PHARMA | 11,420 | -1,21 % | InnoCan Pharma: Nasdaq-Rallye startet jetzt?! | ||
| CRONOS GROUP | 2,172 | +0,28 % | Cronos Group Inc: Cronos makes Sourz gummies available as multipacks | ||
| SYNBIOTIC | 2,620 | -1,87 % | SYNBIOTIC SE: MedCan-Reform verändert die Marktdynamik. Von Kaufen auf Spekulativen Kauf. | Das Bundeskabinett hat einen Gesetzentwurf zur Änderung des Medizinal-Cannabis-Gesetzes verabschiedet, der strengere Vorschriften für Verschreibung und Vertrieb vorsieht - ein klares Signal für die... ► Artikel lesen | |
| GREEN THUMB INDUSTRIES | 7,000 | +0,43 % | Cannabis-Aktien: AKTIONÄR-Tipp Green Thumb dreht auf | Zum Wochenstart verzeichnet der Cannabis-Sektor eine Renencance. Zweistellige Kursgewinne sind dabei keine Seltenheit. Grund für den neuen Boom bei den Kiffer-Aktien: US-Präsident Donald Trump hat ein... ► Artikel lesen | |
| CHRISTINA LAKE CANNABIS | 0,024 | 0,00 % | Christina Lake Cannabis Corp.: Christina Lake Cannabis Announces Debenture Extension | VANCOUVER, British Columbia, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Christina Lake Cannabis Corp. (the "Company" or "CLC" or "Christina Lake Cannabis") (CSE: CLC) (OTCQB: CLCFF) (FRANKFURT: CLB) announces... ► Artikel lesen | |
| AXSOME THERAPEUTICS | 106,90 | +1,96 % | Axsome Therapeutics, Inc.: Axsome Therapeutics Recognizes Mental Illness Awareness Week Along with the National Advocacy Community | ||
| JAZZ PHARMACEUTICALS | 117,35 | +0,56 % | Jazz Pharma: FDA Approves Zepzelca + Tecentriq Combo For First-Line Maintenance In ES-SCLC Patients | WASHINGTON (dpa-AFX) - Jazz Pharmaceuticals plc (JAZZ) announced that it has received U.S. FDA approval for Zepzelca (lurbinectedin) in combination with either atezolizumab (Tecentriq) or atezolizumab... ► Artikel lesen | |
| JAGUAR HEALTH | 2,070 | 0,00 % | Jaguar Health, Inc.: Jaguar Health Completes Meeting with FDA for Advice on Development Pathways to Advance Ongoing Crofelemer Trial for Potential Approval for Treatment of Pediatric Indication Microvillus Inclusion Disease | Additional update: Results of ongoing investigator-initiated proof-of-concept trial in United Arab Emirates (UAE) demonstrate further reduction of total parenteral support (PS) (comprised of total parenteral... ► Artikel lesen | |
| TRULIEVE CANNABIS | 6,985 | +3,48 % | Trulieve Cannabis Corp.: Trulieve Announces Appointment of Board Member Matthew Foulston and Chief Financial Officer Jan Reese | TALLAHASSEE, Fla., Aug. 27, 2025 /PRNewswire/ -- Trulieve Cannabis Corp. (CSE: TRUL ) (OTCQX: TCNNF ) ("Trulieve" or "the Company"), a leading and top-performing... ► Artikel lesen | |
| CORBUS PHARMACEUTICALS | 13,600 | +1,49 % | Corbus Pharmaceuticals Holdings, Inc.: FDA Grants Fast Track Designation to Corbus Pharmaceuticals' Nectin-4 Targeting ADC CRB-701 in Head and Neck Squamous Cell Carcinoma | Dose optimization data from the Phase 1/2 study to be presented next month at ESMO 2025Second Fast Track designation granted by FDA for CRB-701 NORWOOD, Mass., Sept. 16, 2025 (GLOBE NEWSWIRE) -- Corbus... ► Artikel lesen | |
| AVALO THERAPEUTICS | 12,080 | +0,67 % | Avalo Therapeutics, Inc. - 8-K, Current Report |
Das Unternehmen FILAMENT HEALTH CORP kann der Branche Pharma zugeordnet werden. Der aktuelle Kurs liegt bei 0,010 Euro und damit 0,00 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu FILAMENT HEALTH CORP finden Sie auf Wallstreet Online.